Results

Total Results: 1,430 records

Showing results for "continued".

41. Layout 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-insulin_executive.pdf
    September 01, 2008 - 00 P.M. and insulin aspart 70/30 was given once daily 10 minutes before dinner, with metformin being continued … findings on comparative effectiveness of premixed insulin analogues and other antidiabetic agents (continued … findings on comparative effectiveness of premixed insulin analogues and other antidiabetic agents (continued … ) Outcome and Strength of Summary comparison agent evidence Weight change (continued) Long-acting … findings on comparative effectiveness of premixed insulin analogues and other antidiabetic agents (continued

42. CER 222: Evidence Summary: Achieving Health Equity in Preventive Services (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-222-evidence-summary-health-equity.pdf
    January 01, 2020 - Summary of evidence for Key Question 2: effect of impediments and barriers of populations (continued … Summary of evidence for Key Question 2: effect of impediments and barriers of populations (continued … Summary of evidence for Key Question 3: effectiveness of patient-provider approaches (continued) … Summary of evidence for Key Question 4: effectiveness of health information technologies (continued) … Summary of evidence for Key Question 5: effectiveness of health system interventions (continued)

43. Layout 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-pci-bypass_executive.pdf
    October 01, 2007 - Brief overview of reviewed randomized controlled trials (continued) 10 Poland … Brief overview of reviewed randomized controlled trials (continued) Abbreviations: BMS=bare-metal stent … CABG (continued) 13 Key Questions and Strength of outcomes evidencea Summary, conclusions … , and comments Long-term outcomes (continued) Key Question 2b. … , and comments Long-term outcomes (continued) Key Question 2e.

44. Reducing Hospital Length of Stay Supplemental Info (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/topic-nom-length-stay-supplement.pdf
    June 27, 2019 - upon discharge, partnering with home health care and long-term care facilities to provide options for continued

45. Treatment of Dementia Among Community-Dwelling and Institutionalized Medicare Beneficiaries (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/dementia-databases-methods_research.pdf
    May 01, 2008 - 145,403 7.3 (0.95) 64,669 4.8 (0.87) Non-Hispanic 1,856,377 92.7 (0.95) 1,330,192 95.2 (0.87) (continued … beneficiaries with dementia in MCBS 2002 by residential setting (weighted to be nationally representative) (continued … coverage 394,031 19.7 (1.61) 249,791 17.9 (1.85) Medicare only 149,529 7.5 (1.26) 145,612 10.4 (1.24) (continued … 84 266,133 29.4 (2.58) 196,355 37.3 (3.50) 85+ 134,142 22.8 (2.56) 127,929 19.4 (2.24) (continued … Midwest 96,136 22.7 (3.82) 122,010 29.3 (4.01) West 124,749 28.7 (3.61) 45,995 21.1 (4.18) (continued

46. Layout 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/ace-inhibitor-arb-update_executive.pdf
    June 01, 2011 - benefits and harms of ACEIs, ARBs, and direct renin inhibitors for adults with essential hypertension (continued … hypertension, how do ACEIs, ARBs, and direct renin inhibitors differ in the following health outcomes (continued … benefits and harms of ACEIs, ARBs, and direct renin inhibitors for adults with essential hypertension (continued … (continued) compared with the withdrawal rate associated with ACEIs.

47. Layout 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer18-heart-disease-ace-inhibitor-arb-executive.pdf
    October 01, 2009 - Cardiovascular Moderate • ACE inhibitor therapy is similar to placebo in patients mortality (continued … Stroke (continued) Moderate • ACE inhibitor therapy is similar to calcium channel blockers in patients … Hypotension Low • The risk of hypotension with ACE inhibitor therapy is (continued) greater than with … Hypertension Low • ARB therapy (telmisartan) impacts the composite efficacy (continued) endpoint of … Beta-blockers Insufficient • The impact of ACE inhibitors, ARBs, and their (continued) combination on

48. Pressure-Ulcer-Treatment Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/pressure-ulcer-treatment_executive.pdf
    May 01, 2013 - (continued) Nutrition Protein-containing nutritional supplements Moderate When used in addition to … (continued) Local Wound Applications (continued) Platelet-derived growth factor Low Platelet-derived … (continued) Local Wound Applications Local wound applications, all strategies Insufficient Few studies … (continued) Harms: Local Wound Applications Dressings and topical therapies Moderate Harms reported … (continued) Harms: Surgery Surgery, all strategies Low Wound dehiscence was more common if bone was

49. Horizon Scanning Protocol and Operations Manual September 2015 Revision (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/ahrq-healthcare-horizon-scan-protocol-operations-manual-151001.pdf
    September 01, 2015 - Questions considered about drugs, biologics, and devices (continued) f. … Algorithm for assessing and sorting leads to identify possible topics (continued) d. … Meeting abstracts reviewed for leads (continued) A-14 Resource Name and Type (1-11; see Key at … Meeting abstracts reviewed for leads (continued) A-15 Resource Name and Type (1-11; see Key at … Meeting abstracts reviewed for leads (continued) A-16 Resource Name and Type (1-11; see Key at

50. Horizon Scanning Protocol and Operations Manual September 2015 Revision (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/ahrq-healthcare-horizon-scan-protocol-operations-manual-151001.pdf
    September 01, 2015 - Questions considered about drugs, biologics, and devices (continued) f. … Algorithm for assessing and sorting leads to identify possible topics (continued) d. … Meeting abstracts reviewed for leads (continued) A-14 Resource Name and Type (1-11; see Key at … Meeting abstracts reviewed for leads (continued) A-15 Resource Name and Type (1-11; see Key at … Meeting abstracts reviewed for leads (continued) A-16 Resource Name and Type (1-11; see Key at

51. Management of Infantile Hemangioma (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/infantile-hemangioma_clinician.pdf
    June 01, 2016 - Overview of the Clinical Evidence (Continued) Table 2: Summary of Findings and Strength of Evidence … Continued on page 4 Archived: This report is greater than 3 years old. … Gaps in Knowledge and Limitations of the Evidence Base (Continued from page 3) ��Evidence related to

52. Layout 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_executive.pdf
    September 01, 2011 - Among children who have responded to a biologic DMARD, randomized discontinuation trials show that continued … Summary of the evidence on comparative effectiveness and harms of DMARDs for childhood JIA (continued … In children with JIA, what are the comparative effects of DMARDs on: (continued) d. … Summary of the evidence on comparative effectiveness and harms of DMARDs for childhood JIA (continued

53. Evidence Report No. 222, Data Linkage Strategies To Advance Youth Suicide Prevention (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/suicide-prevention_research.pdf
    October 01, 2016 - Environmental scan coding schema (continued) ID# Topics Level Type Must Code 1 URL - additional … Environmental scan coding schema (continued) ID# Topics Level Type Must Code 2 Islands 4 Y/N/? … Environmental scan coding schema (continued) ID# Topics Level Type Must Code 2 Oregon (OR) 3 Y/N … Environmental scan coding schema (continued) ID# Topics Level Type Must Code 8 Intervention(s) 2 … Characteristics of studies identified in the literature search (continued) Program or Study Name

54. Angina-Heart-Attack-Treatments Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/angina-heart-attack-treatments_executive.pdf
    January 01, 2014 - Antiplatelet therapy initiated during a hospitalization for UA/NSTEMI and continued for long-term management … Summary strength of evidence and effect estimates: 300 mg versus 600 mg clopidogrel loading dose (continued … Heparin-Based Strategy With Planned GPI Use (continued) Nonfatal MI at 30 days SOE = Moderate (3 RCTs … versus unfractionated heparin versus fondaparinux (percutaneous coronary intervention cohort) (continued … Summary strength of evidence and effect estimates: dual antiplatelet versus triple therapya (continued

55. SRDR-Charter-140305 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/data-repository-reviews-charter-140305.pdf
    June 01, 2012 - The Brown  EPC has now assumed the responsibility  for the continued development and maintenance … team before data can  be publicly viewable. -­‐ Coordination of governance board  meetings. -­‐ Continued

56. Continuous-Outcomes-Quantitative-Synthesis Methods (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/continuous-outcomes-quantitative-synthesis_methods.pdf
    March 01, 2011 - Methods Guide for Comparative Effectiveness Reviews Handling Continuous Outcomes in Quantitative Synthesis ii This report is based on research conducted by the Oregon Evidence-based Practice Center (EPC) under contract to the Agency for Healthcare…

57. Evidence Summary_Comparative Effectiveness Review No. 248: Prehabilitation and Rehabilitation for Major Joint Replacement (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/joint-replacement-evidence%20-summary.pdf
    November 01, 2021 - (continued on page 2) 2 Background and Purpose Total joint replacement, which … • Rehabilitation for Total Knee Arthroplasty (continued) o No studies addressed the risk of harms

58. TND-612-09-03-2013 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-612-09-03-2013.pdf
    January 01, 2013 - transition planning to adult care without loss or discontinuity of services, satisfaction with care, continued

59. Executive Summary_Comparative Effectiveness Review No. 253: Maternal and Child Outcomes Associated With the Special Supplemental Nutritional Program for Women, Infants, and Children (WIC) (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-253-maternal-child-outcomes-wic-executive-summary.pdf
    April 01, 2022 - (continued on page 2) 2 Infant and Child Health Outcomes (continued) • The evidence was insufficient

60. Medication-Therapy-Management Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/medication-therapy-management_executive.pdf
    November 01, 2014 - and Exclusion Criteria and Relevant Factors for Study Abstraction Outcomes (continued) Inclusion … criteria: (continued) – Harms � Care fragmentation � Patient confusion � Patient decisional … Populations, interventions, comparators, outcomes, timing, and settings (continued) 8 Methods Topic … Summary of findings and strength of evidence for intermediate outcomes of MTM interventions (continued … Summary of findings and strength of evidence for intermediate outcomes of MTM interventions (continued